By expenditures
| Name | Title | Type |
|---|---|---|
| Rafael Nieves | Partner | Auditee |
| Neysa Lopez | Comptroller | Auditee |
| Taireli Hidalgo, Cpa, Fhfma | Audit and Assurance Manager | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 351279 | 2024 | 2025-03-31 | Galindez LLC | $174.57M |
| 310538 | 2023 | 2024-06-27 | Galindez LLC | $127.72M |
| 14757 | 2022 | 2024-01-31 | Galindez LLC | $99.06M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 351279 | 2024 | 2025-03-31 | 1123363 | 2024-002 | Material Weakness | Yes | A |
| 351279 | 2024 | 2025-03-31 | 546921 | 2024-002 | Material Weakness | Yes | A |
| 310538 | 2023 | 2024-06-27 | 979907 | 2023-004 | Significant Deficiency | Yes | L |
| 310538 | 2023 | 2024-06-27 | 979906 | 2023-004 | Significant Deficiency | Yes | L |
| 310538 | 2023 | 2024-06-27 | 979905 | 2023-004 | Significant Deficiency | Yes | L |
| 310538 | 2023 | 2024-06-27 | 979904 | 2023-004 | Significant Deficiency | Yes | L |
| 310538 | 2023 | 2024-06-27 | 979903 | 2023-003 | Material Weakness | - | A |
| 310538 | 2023 | 2024-06-27 | 403465 | 2023-004 | Significant Deficiency | Yes | L |
| 310538 | 2023 | 2024-06-27 | 403464 | 2023-004 | Significant Deficiency | Yes | L |
| 310538 | 2023 | 2024-06-27 | 403463 | 2023-004 | Significant Deficiency | Yes | L |
| 310538 | 2023 | 2024-06-27 | 403462 | 2023-004 | Significant Deficiency | Yes | L |
| 310538 | 2023 | 2024-06-27 | 403461 | 2023-003 | Material Weakness | - | A |
| 14757 | 2022 | 2024-01-31 | 587389 | 2022-006 | Significant Deficiency | - | A |
| 14757 | 2022 | 2024-01-31 | 587388 | 2022-005 | Significant Deficiency | Yes | L |
| 14757 | 2022 | 2024-01-31 | 587387 | 2022-004 | Significant Deficiency | Yes | L |
| 14757 | 2022 | 2024-01-31 | 587386 | 2022-006 | Significant Deficiency | - | A |
| 14757 | 2022 | 2024-01-31 | 587385 | 2022-005 | Significant Deficiency | Yes | L |
| 14757 | 2022 | 2024-01-31 | 587384 | 2022-004 | Significant Deficiency | Yes | L |
| 14757 | 2022 | 2024-01-31 | 587383 | 2022-006 | Significant Deficiency | - | A |
| 14757 | 2022 | 2024-01-31 | 587382 | 2022-005 | Significant Deficiency | Yes | L |
| 14757 | 2022 | 2024-01-31 | 587381 | 2022-004 | Significant Deficiency | Yes | L |
| 14757 | 2022 | 2024-01-31 | 10947 | 2022-006 | Significant Deficiency | - | A |
| 14757 | 2022 | 2024-01-31 | 10946 | 2022-005 | Significant Deficiency | Yes | L |
| 14757 | 2022 | 2024-01-31 | 10945 | 2022-004 | Significant Deficiency | Yes | L |
| 14757 | 2022 | 2024-01-31 | 10944 | 2022-006 | Significant Deficiency | - | A |
| 14757 | 2022 | 2024-01-31 | 10943 | 2022-005 | Significant Deficiency | Yes | L |
| 14757 | 2022 | 2024-01-31 | 10942 | 2022-004 | Significant Deficiency | Yes | L |
| 14757 | 2022 | 2024-01-31 | 10941 | 2022-006 | Significant Deficiency | - | A |
| 14757 | 2022 | 2024-01-31 | 10940 | 2022-005 | Significant Deficiency | Yes | L |
| 14757 | 2022 | 2024-01-31 | 10939 | 2022-004 | Significant Deficiency | Yes | L |